Ozlem Cakici

Ozlem Cakici

Auto-generated profile, based on publicly available information

Ozlem Cakici

Department of Pediatric Infectious Diseases, Sivas Numune Hospital, Sivas, Türkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
DCDilek Yilmaz Ciftdogan
Dilek Yilmaz Ciftdogan
YKYıldız Ekemen keleş
Yıldız Ekemen keleş
BCBenhur Sirvan Cetin
Benhur Sirvan Cetin
NKNazan Dalgic Karabulut
Nazan Dalgic Karabulut
MEMelike Emiroglu
Melike Emiroglu
AKAteş Kara
Ateş Kara

24 February 2022 in Cureus
Verified
Journal Article
Open access
Selim ÖNCELSelim ÖNCEL
Selim ÖNCEL
MAMüge Alvur
Müge Alvur
ÖÇÖzlem Çakıcı
Özlem Çakıcı
As in many other countries, healthcare workers (HCWs) have been identified as the priority group for vaccination in Turkey for they are in close contact with not only patients with COVID-19 to whom they provide treatment but also asymptomatic individuals with COVID-19 infection while inoculating COVID-19 vaccines. As a result of this prioritization, they will always be in the limelight and regarded as role models for personal and parental acceptance of COVID-19 vaccines. Turkish healthcare workers (n=1,808) were contacted and invited to fill out an online questionnaire between December 27, 2020, and January 14, 2021, in order to reveal their approaches to COVID-19 vaccines and vaccination. Most of the participants had moderate concerns of having severe COVID-19. Anxiety on the adverse effects of COVID-19 vaccines was more prevalent in females and among 36- to 50-year-old healthcare workers and less frequent in physicians, nurses, and midwives and in those with a higher level of knowledge about COVID-19 vaccines. Strict anti-vaccination tendency was higher in professional categories other than physicians, nurses, and midwives. Females, physicians, nurses, midwives, healthcare workers aged 51 and over, healthcare workers having children, married healthcare workers, and healthcare workers who use scientific journals and World Health Organization (WHO) announcements as sources of information were more inclined to accept COVID-19 vaccines. The elimination of COVID-19 vaccine hesitancy in healthcare workers would be possible if people around them, physicians, and ministers or high officials get vaccinated but will persist in 19% of the healthcare workers. More than half of the healthcare workers thought vaccination against COVID-19 should not be mandatory. The Pfizer-BioNTech vaccine was the most preferred COVID-19 vaccine (37.3%). The reasons for this preference were the trustworthiness of the country of origin, the manufacturer company, the Turkish origin of its developers, the vaccine’s being the first to receive emergency validation, and its non-Indian, non-Russian, and non-Chinese origin. Parental vaccine refusal and hesitancy were present in 15.6% and 31.9% of the healthcare workers, respectively. The mistrust in COVID-19 vaccines among Turkish healthcare workers was directed toward not only pharmaceutical companies but also health authorities and academicians because of their unconvincing, conflicting, or vague statements and toward certain countries known for their production of low-quality merchandise in the past. The parental COVID-19 vaccine hesitancy of 32% of the healthcare workers is unacceptably high for role modeling against anti-vaccine movement and should be diminished by implementing necessary measures as soon as possible.

11 June 2026 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
OCOzlem Cakici
Ozlem Cakici
Kubra AykacKubra Aykac
Kubra Aykac
BSBera Enes Seyrek
Bera Enes Seyrek
IYİsMail Cem Yılmaz
İsMail Cem Yılmaz
ODOsman Oguz Demir
Osman Oguz Demir
YOYasemin Ozsurekci
Yasemin Ozsurekci
: Tularemia is a rare zoonotic infection with marked geographic clustering and long interepidemic periods. Pediatric data, particularly those on host immune responses during active disease and treatment, remain scarce. The authors aimed to evaluate clinical characteristics and treatment-associated cytokine dynamics in children with tularemia. In the present multicenter prospective study conducted in Türkiye, 40 pediatric patients with laboratory-confirmed tularemia and nine age- and sex-matched healthy controls were enrolled between April 2023 and November 2024. Clinical features, exposure history, and treatment outcomes were recorded. Serum cytokine levels, including interleukin (IL)-6, IL-2, IL-9, IL-5, IL-13, tumor necrosis factor-α, IL-10, interferon (IFN)-γ, IL-4, and IL-22, were measured using a multiplex bead-based assay and compared between patients and controls, between good and poor outcome groups, and longitudinally before and after therapy. A good outcome was defined as complete clinical resolution without suppuration, the need for surgical intervention, or relapse, whereas a poor outcome was defined as clinical nonresolution or progression. A total of 24 (60%) participants had a good outcome, and 16 (40%) had a poor outcome. Although baseline cytokine levels did not differ between groups, paired analyses revealed significant posttreatment reductions in IFN-γ ( P = 0.018), IL-6 ( P = 0.018), and IL-10 ( P = 0.032), consistent with resolution of infection-associated immune activation. A poor outcome was associated with increased exposure to natural water sources and a higher frequency of suppurative lymphadenopathy requiring surgical drainage. Baseline cytokine profiles did not predict treatment response; however, dynamic changes in IFN-γ, IL-6, and IL-10 were associated with clinical recovery. These findings highlight the importance of longitudinal immune monitoring and provide insight into immune dynamics in pediatric tularemia.

7 September 2023 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
ADAsuman Demirbuğa
Asuman Demirbuğa
STSelda Hançerli Törün
Selda Hançerli Törün
ÖMÖzge Metin-Akcan
Özge Metin-Akcan
AYAylin Yucel
Aylin Yucel
AYAysun Yahşi
Aysun Yahşi
OGon behalf of the TURK-Adenovirus Hepatitis Study Group
on behalf of the TURK-Adenovirus Hepatitis Study Group
Background: In the first half of 2022, the increase in cases of severe acute hepatitis in children with no epidemiological link and unknown cause has aroused concern worldwide. In this study, we aimed to determine the frequency of adenovirus in children with hepatitis of unknown origin in Turkey. Methods: In this study, which was conducted with the participation of 16 centers from Turkey, between July 2022 and January 2023, 36 pediatric patients under the age of 18 who met the definition of acute hepatitis were included. Results: Twenty (55,6%) of patients were female and 16 (44,4%) were male, with a mean age of 41.55 ± 39.22 (3-192) months. The most common symptoms were fever (66.7%), weakness (66.7%), loss of appetite (66.7%), fatigue (61.1%), vomiting (61.1%), and diarrhea (47.2%). Six (16 %) children had acute hepatic failure. Eight of the 15 children (46%) had respiratory viral infections (rhinovirus/enterovirus, n = 4; rhinovirus + parainfluenza, n = 1; parainfluenza, n = 1, SARS-CoV-2 n = 2). Adenovirus was detected in 16 (44%) patients. Adenovirus and coinfections were detected in 7 patients. History of diarrhea and fatigue in the last month was significantly higher in the adenovirus group (P = 0.023 and 0.018). One child who had both adenovirus and rhinovirus infection required liver transplantation; all others recovered with supportive care. Conclusion: There were no deaths in our series; however, the number of cases, etiology, and severity of the clinical course may have differed between countries owing to differences in case definitions, laboratory facilities, or regional genetic differences.

31 December 2024 in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
Verified
Journal Article
Closed access
ÖÇÖzlem Çakıcı
Özlem Çakıcı
Bağışıklama en etkili koruyucu sağlık önlemlerinden biridir. Sağlık kurumuna herhangi bir nedenle başvuran her bireyin aşılanma durumu kontrol edilmeli ve herhangi bir kontrendikasyon yoksa eksik aşıları mutlaka yapılmalıdır. Aşı uygulayan kişilerin aşıları doğru şekilde nasıl uygulanacağı, kontrendikasyonların nasıl yönetileceği ve aşılama sonrası reaksiyonları nasıl tanıyacağı da dahil olmak üzere aşılama prosedürünü anlamaları oldukça önem arz etmektedir. Aşılarla ilgili endikasyonların, kontrendikasyonların, dikkatli olunması gereken durumların ve özellikli durumlarda aşılamaların tüm hekimler tarafından bilinmesi gerekmektedir. Aşı uygulanan kişilerde ideal immun yanıtın elde edilebilmesi için aşıların önerilen zamanda, uygun doz ve yöntemle uygulanması gereklidir. Ayrıca aşılama sırasında riskleri en aza indirmek ve hasta güvenliğini sağlamak aşı uygulamalarının temelini oluşturmaktadır. Bu derlemede aşılama ile ilgili temel bilgiler ve aşı uygulamalarında dikkat edilmesi gereken hususlar belirtilmiştir.

1 January 2026 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
Kubra AykacKubra Aykac
Kubra Aykac
OCOzlem Cakici
Ozlem Cakici
AKAylin Irmak Kuruc
Aylin Irmak Kuruc
CÖCanan Özlü
Canan Özlü
PKPınar Koc
Pınar Koc
YOYasemin Ozsurekci
Yasemin Ozsurekci